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• Patients are generally content for most of their
confidential medical information to be shared with most
groups.
• Patients believe it is important to be asked about, and
involved in, any decisions regarding sharing of their
confidential information with people not involved with
their health care.
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Prescription of paracetamol-containing
medications as indicator of quality of
prescribing
SIR—Paracetamol is widely prescribed for mild to moderate
pain and pyrexia. It is available as a single ingredient and also
in combination with opiate analgesics such as codeine and
dihydrocodeine. The recommended dose of paracetamol for
adults is 0.5 to 1 g every 4–6 h to a maximum of 4 g in a
given 24-h period [1].
Hepatotoxicity is rare if doses of paracetamol <12 g
(or 150 mg/kg body weight) are ingested [2] although
it is described [3, 4]. Patients with poor nutrition are
particularly at risk of hepatotoxicity even at doses within
the recommended range [5]. This may be relevant for older
people in hospital as the prevalence of malnutrition is known
to be high in this population [6]. However, we are not
aware of clinical trial evidence to suggest that older people
should have a lower recommended dose. In fact, the current
recommended dose is not based on randomised controlled
trial data. Using a single intravenous dose of 500 mg of
paracetamol, Wynne et al. showed paracetamol clearance to
decrease with age and frailty [7]. Miners et al. showed that
after administering a single oral dose of 1 g of paracetamol
the total clearance and clearance by glucuronidation did not
change with age although there was a reduction in clearance
by sulphation and renal clearance [8]. Interestingly there was
no age effect on the cytochrome P450 mediated clearance of
the reactive toxic metabolite. This has also been seen in rat
studies [9].
While deliberate overdose of paracetamol is well known,
inadvertent, iatrogenic over-dosage is less well recognised.
The National Sentinel Audit of Evidence Based Prescribing
for Older People supported improvements in prescribing
by measuring the quality of prescribing practice [10].
We report here on the prescription of paracetamol and
paracetamol-containing preparations in 102 hospitals that
participated in the audit and give an estimate of the risk of
exceeding the recommended dose of paracetamol. The data
were collected prior to the withdrawal of Co-Proxamol,
dextropropoxyphene in combination with paracetamol,
withdrawn in January 2005, because of poorly established
efficacy and unacceptable risk of toxicity in overdose [11].
Methods
Hospitals in England and Wales were invited to volunteer
to participate in the study in 1999 and 102 hospitals agreed.
Prescribing data on paracetamol-containing medications
were collected from drug charts of 100 consecutive medical
in-patients aged 65 years or older on a selected day for each
hospital. Data collected included the dose and frequency of
all paracetamol containing medications prescribed. The total
paracetamol content in milligrams prescribed to patients
was evaluated over a 24 h period. We did not collect
data on medications actually administered and nurses did
not prescribe. Patients were considered to be at risk of
overdosage if there was the potential to be administered over
4 g of paracetamol in 24 h.
Results
Data were collected for 9,979 patients. Of these, 9,927
patients had one or more drugs prescribed. Among these
patients 6,141 (62%) were prescribed 6,560 medications
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containing paracetamol. Apart from paracetamol tablets,
four combination preparations were prescribed (Table 1).
Data to enable estimation of total dosage was complete for
only 6,060 patients prescribed 6,465 medications containing
paracetamol (Table 2). There was a potential risk of a
paracetamol overdosage for 732/6,060 (12%) of patients
prescribed medication containing paracetamol. The risk of
the potential for overdosage increased with the number of
paracetamol-containing medications prescribed per patient.
The percentage of patients at risk of potential overdosage was
low (7%) when only one paracetamol-containing medication
was prescribed. However, the risk increased dramatically to
90% when two paracetamol-containing medications were
prescribed and to 100% with three or more paracetamol-
containing medications (Table 2). Data were collected a year
later in the second loop of the audit cycle and no significant
changes were found.
Discussion
This study demonstrates that medical in-patients aged
65 years or older are at potential risk, through suboptimal
prescribing, of being administered paracetamol exceeding the
recommended therapeutic dose. The main problems were:
(i) failure to specify the dose frequency; and (ii) prescribing
more than one paracetamol-containing medication.
Although this study was conducted prior to the withdrawal
of Co-Proxamol we do not expect the situation to have
changed much since. As paracetamol is available in a number
of compound analgesic preparations, a common error is
to co-prescribe paracetamol with a compound analgesic
Table 1. Paracetamol-containing
medications prescribed
Name of medication Number of prescriptions







Table 2. The relationship between number of
paracetamol-containing preparations prescribed and the
potential for excessive dosing
No. of paracetamol- No. of patients No. of patients
containing prescribed where excessive
medications paracetamol-containing dosing could have
prescribed medication(s) occurred (%)
per patient
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1 5,668 376 (6.6)
2 368 332 (90.2)
3 or more 24 24 (100)
Total 6,060 732 (12.1)
containing paracetamol and exceed the recommended limit.
Recently, SUREMED, an anonymous self-reporting scheme
for medication errors [12, 13] alerted prescribers in King’s
College Hospital of such duplicate dose errors (internal
communication). The alert advised that when prescribing
analgesics which patients bring into hospital, doctors need
to check the paracetamol content and review the current
medication chart to ensure that no other paracetamol-based
analgesics are prescribed.
The main limitation of our study was the unavailability
of data on clinical endpoints and medications administered,
which the audit was not designed to measure. While data
were collected for 100 consecutive patients over the age of 65
on medical wards on a selected day for each hospital, we do
not have data on the number of all inpatients at the time of
audit. Over 98% of the patients prescribed paracetamol
or paracetamol-containing medication had dosage data
available. We did not feel that we could make a meaningful
comparison between patients with and without dosage data
because the latter group had only 81 patients compared with
6,040 with dosage data available.
Conclusion
Paracetamol is a popular first-line choice for management
of pain and pyrexia in patients of all ages. When used at
recommended doses it seldom causes adverse events [14, 15].
To reduce the risk of exceeding the recommended dose of
paracetamol prescribers should avoid prescribing the drug
as more than one preparation. There is no rationale for
more than two preparations to be prescribed concurrently. In
addition, prescribers should not rely on those who administer
medicines to quantify the total dosage of potentially
harmful drugs. The prescription of multiple preparations of
paracetamol can be used as a marker of quality of prescribing.
As mentioned earlier in this paper, there is no evidence to
suggest a lower recommended dose of paracetamol for
older people. The prevalence of prescriptions allowing the
administration of greater than 4 g of paracetamol in a 24 h
period can be used to reflect the risk of iatrogenic over-dosage
in adult patients in general.
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Key points
• Paracetamol is commonly prescribed as a single ingredient
or as a compound analgesic.
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• The recommended maximum dose of paracetamol for
adults is 4 g in a given 24-h period.
• This study showed that the risk of exceeding this dose is
increased dramatically when more than one paracetamol-
containing medication is prescribed.
• The prevalence of prescriptions allowing the administra-
tion of greater than 4 g of paracetamol in a 24 h period
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Do we really need palliative care for severe
dementia patients?
SIR—The decision about the most appropriate care model
for patients affected by severe dementia and acute somatic
diseases is a major topic in the discussion regarding hospital
processes. With this in mind, we read with interest the
editorial by Parker et al. on ‘Acute hospital care for frail
older people’ and the paper by Zvi Aminoff and Adunsky
recently published in Age and Ageing [1, 2]. We share most
of the statements by the authors regarding the care of
elderly people in the acute hospital setting. Moreover, we
appreciate the attention given to this topic in a period
when geriatric wards are under pressure with the general
trend to reduce acute hospital beds. In particular, the Italian
national agenda is dominated mostly by an emphasis on
developing intermediate care and community services for
older people [3]. Some acute geriatric wards are closing and
others are being converted to departments of ‘low care’ [4].
The remaining geriatric hospital wards have to face the
difficult task of caring for a higher number of old patients
with an increase in the average level of illness severity and
complexity. In order to answer these difficulties we need
to define new models of inpatient units. Special acute care
units for elderly patient (ACE) like sub-intensive care units
for the elderly, stroke units, hip units and delirium units
have been developed. Most of them have been shown to be
effective for specific clinical conditions. However, for many
patients, i.e. those with severe dementia, the effectiveness of
hospital admission has not been completely evaluated, and
new models of care are in the process of being developed.
Among these models, palliative care seems inspired by the
most diffused cultural backgrounds.
In this framework, we would like to present our data, in
order to contribute to the ongoing discussion.
From 1 January to 31 December 2003, there were 1,418
patients who were consecutively admitted to our ward. One
hundred and eight patients were under 65 years of age and
were excluded from the analysis, and 16 patients were lost at
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